Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
163 | 3 | THYROID//THYROID CANCER//HYPOTHYROIDISM | 61271 |
121 | 2 | HYPOTHYROIDISM//HYPERTHYROIDISM//THYROID HORMONE | 23993 |
19037 | 1 | TETRAC//TETRAIODOTHYROACETIC ACID//IMMUNE ENDOCRINE | 547 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | TETRAC | authKW | 776300 | 3% | 84% | 16 |
2 | TETRAIODOTHYROACETIC ACID | authKW | 313686 | 1% | 78% | 7 |
3 | IMMUNE ENDOCRINE | authKW | 282316 | 1% | 70% | 7 |
4 | MOL CELLULAR MED PROGRAM | address | 172849 | 1% | 100% | 3 |
5 | NDAT | authKW | 172849 | 1% | 100% | 3 |
6 | TRANSLAT HEMATOONCOL | address | 144036 | 1% | 50% | 5 |
7 | AVIAN IMMUNE FUNCTIONS | authKW | 115233 | 0% | 100% | 2 |
8 | L THYROXINE T 4 | authKW | 115233 | 0% | 100% | 2 |
9 | MOLEC CELLULAR DEV BIOL CAMPUS BOX 347 | address | 115233 | 0% | 100% | 2 |
10 | NANOPHARMACEUTICAL TECHNOLOGY | authKW | 115233 | 0% | 100% | 2 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 2536 | 27% | 0% | 146 |
2 | Oncology | 1111 | 25% | 0% | 135 |
3 | Immunology | 236 | 12% | 0% | 63 |
4 | Cell Biology | 188 | 11% | 0% | 62 |
5 | Medicine, Research & Experimental | 92 | 6% | 0% | 33 |
6 | Physiology | 66 | 5% | 0% | 26 |
7 | CYTOLOGY & HISTOLOGY | 63 | 1% | 0% | 3 |
8 | Biochemistry & Molecular Biology | 25 | 10% | 0% | 57 |
9 | Medicine, General & Internal | 23 | 5% | 0% | 26 |
10 | Biology | 19 | 2% | 0% | 13 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MOL CELLULAR MED PROGRAM | 172849 | 1% | 100% | 3 |
2 | TRANSLAT HEMATOONCOL | 144036 | 1% | 50% | 5 |
3 | MOLEC CELLULAR DEV BIOL CAMPUS BOX 347 | 115233 | 0% | 100% | 2 |
4 | TAIPEI INT CANC | 115233 | 0% | 100% | 2 |
5 | TAIPEI CANC | 112957 | 2% | 20% | 10 |
6 | CHIRURGIA GEN GASTROENTEROL MAMMARIA | 57616 | 0% | 100% | 1 |
7 | COMPETENCE SPECIAL GYNECOL | 57616 | 0% | 100% | 1 |
8 | CONICETPRIMERA CATEDRA FARMACOL | 57616 | 0% | 100% | 1 |
9 | CONSEJO NACL INVEST CIENT TECN INVEST BIOQU | 57616 | 0% | 100% | 1 |
10 | FARM BIOQUIM FFYB | 57616 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HORMONES & CANCER | 8564 | 1% | 3% | 5 |
2 | ENDOCRINOLOGIA EXPERIMENTALIS | 2803 | 1% | 1% | 4 |
3 | DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY | 1856 | 2% | 0% | 11 |
4 | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 1635 | 2% | 0% | 12 |
5 | STEROIDS | 1568 | 2% | 0% | 11 |
6 | ADVANCES IN NEUROIMMUNOLOGY | 1360 | 0% | 1% | 2 |
7 | CYTOBIOS | 1306 | 1% | 0% | 5 |
8 | JOURNAL OF CHRONIC DISEASES | 1196 | 1% | 1% | 4 |
9 | IMMUNOLOGICAL COMMUNICATIONS | 1058 | 0% | 1% | 2 |
10 | ACTA ENDOCRINOLOGICA | 930 | 1% | 0% | 8 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TETRAC | 776300 | 3% | 84% | 16 | Search TETRAC | Search TETRAC |
2 | TETRAIODOTHYROACETIC ACID | 313686 | 1% | 78% | 7 | Search TETRAIODOTHYROACETIC+ACID | Search TETRAIODOTHYROACETIC+ACID |
3 | IMMUNE ENDOCRINE | 282316 | 1% | 70% | 7 | Search IMMUNE+ENDOCRINE | Search IMMUNE+ENDOCRINE |
4 | NDAT | 172849 | 1% | 100% | 3 | Search NDAT | Search NDAT |
5 | AVIAN IMMUNE FUNCTIONS | 115233 | 0% | 100% | 2 | Search AVIAN+IMMUNE+FUNCTIONS | Search AVIAN+IMMUNE+FUNCTIONS |
6 | L THYROXINE T 4 | 115233 | 0% | 100% | 2 | Search L+THYROXINE+T+4 | Search L+THYROXINE+T+4 |
7 | NANOPHARMACEUTICAL TECHNOLOGY | 115233 | 0% | 100% | 2 | Search NANOPHARMACEUTICAL+TECHNOLOGY | Search NANOPHARMACEUTICAL+TECHNOLOGY |
8 | NANOTETRAC | 115233 | 0% | 100% | 2 | Search NANOTETRAC | Search NANOTETRAC |
9 | TETRAC NANOPARTICLES | 115233 | 0% | 100% | 2 | Search TETRAC+NANOPARTICLES | Search TETRAC+NANOPARTICLES |
10 | INTEGRIN ALPHA V BETA 3 | 85527 | 3% | 11% | 14 | Search INTEGRIN+ALPHA+V+BETA+3 | Search INTEGRIN+ALPHA+V+BETA+3 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |